These companies own 97% of the weight loss drug market -- which could grow tenfold over the next decade -- and are developing next-generation offerings.

PLTR surges 69% YTD as AIP adoption explodes, but its sky-high valuation leaves little room for error near term.

Monday’s news that Warner Bros Discovery is splitting into two companies – one consisting of studios and streaming, the other ...